BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis. Rheum Dis Clin North Am 2013;39:365-81. [PMID: 23597969 DOI: 10.1016/j.rdc.2013.02.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ouchani M, Bachir H, Hamaz S, Alaoui H, Serraj K. Retroperitoneal Fibrosis: Beware of Lymphoma. Cureus 2021;13:e17587. [PMID: 34646640 DOI: 10.7759/cureus.17587] [Reference Citation Analysis]
2 Ali SK, Du K, Orare K. Idiopathic Retroperitoneal Fibrosis: An East African Diagnostic Challenge. Cureus 2021;13:e15683. [PMID: 34277272 DOI: 10.7759/cureus.15683] [Reference Citation Analysis]
3 Li R, Fei S, Lv Y, Kong X, Mao W. A case of idiopathic retroperitoneal fibrosis presenting as gallbladder carcinoma. BMC Surg 2021;21:162. [PMID: 33765983 DOI: 10.1186/s12893-021-01162-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pacella JC, Niwattisaiwong S, Newman D. IgG4-Related Retroperitoneal Fibrosis: A Rare Association With Riedel's Thyroiditis. Cureus 2021;13:e13997. [PMID: 33884241 DOI: 10.7759/cureus.13997] [Reference Citation Analysis]
5 Wang K, Wang Z, Zeng Q, Zhu L, Gao J, Wang Z, Zhang S, Yang F, Shen D, Wang Y, Liu Y. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS One 2021;16:e0245601. [PMID: 33600452 DOI: 10.1371/journal.pone.0245601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fenaroli P, Maritati F, Vaglio A. Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis. Curr Rheumatol Rep 2021;23:18. [PMID: 33569638 DOI: 10.1007/s11926-020-00966-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Roussel E, Callemeyn J, Van Moerkercke W. Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature. Acta Clin Belg 2020;75:239-44. [PMID: 31035909 DOI: 10.1080/17843286.2019.1609152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Peng L, Zhang P, Li J, Liu Z, Lu H, Zhu L, Wang X, Teng F, Li X, Guo H, Fei Y, Zhang W, Zhao Y, Zeng X, Zhang F. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Res Ther 2020;22:103. [PMID: 32366271 DOI: 10.1186/s13075-020-02197-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
9 Koike Y, Matsui S, Takase K, Tannai H. CT-Guided Percutaneous Needle Biopsy in Patients with Suspected Retroperitoneal Fibrosis: A Retrospective Cohort Study. Cardiovasc Intervent Radiol 2019;42:1434-40. [PMID: 31292673 DOI: 10.1007/s00270-019-02266-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Raffiotta F, da Silva Escoli R, Quaglini S, Rognoni C, Sacchi L, Binda V, Messa P, Moroni G. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse. Am J Kidney Dis 2019;74:742-50. [PMID: 31204195 DOI: 10.1053/j.ajkd.2019.04.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
11 Palmisano A, Maritati F, Vaglio A. Chronic Periaortitis: an Update. Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0789-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Cohan RH, Shampain KL, Francis IR, Davenport MS, Stuart Wolf J, Marder W, Swartz RD. Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made? Abdom Radiol (NY) 2018;43:1204-14. [PMID: 28849414 DOI: 10.1007/s00261-017-1282-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Liao S, Wang Y, Li K, Zhu J, Zhang J, Huang F. Idiopathic retroperitoneal fibrosis: a cross-sectional study of 142 Chinese patients. Scandinavian Journal of Rheumatology 2018;47:198-205. [DOI: 10.1080/03009742.2017.1363280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Sanchez-Alvarez C, Bowman AW, Menke DM, Wang B. IgG4 Isolated Retroperitoneal Fibrosis and Aneurysmal Periaortitis. Am J Med 2017;130:e521-4. [PMID: 28882661 DOI: 10.1016/j.amjmed.2017.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Jadhav KK, Kumar V, Punatar CB, Joshi VS, Sagade SN. Retroperitoneal fibrosis-clinical presentation and outcome analysis from urological perspective. Investig Clin Urol 2017;58:371-7. [PMID: 28868510 DOI: 10.4111/icu.2017.58.5.371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
16 Wang Y, Guan Z, Gao D, Luo G, Li K, Zhao Y, Wang X, Zhang J, Jin J, Zhao Z, Yang C, Zhang J, Zhu J, Huang F. The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum 2018;47:593-600. [PMID: 28958769 DOI: 10.1016/j.semarthrit.2017.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
17 Zahran MH, Osman Y, Soltan MA, Abolazm AE, Ghazy MK, Harraz AM, Shokeir AA, Abol-enein H, Ali-el-dein B. Idiopathic retroperitoneal fibrosis: clinical features and long-term renal function outcome. Int Urol Nephrol 2017;49:1327-34. [DOI: 10.1007/s11255-017-1608-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Alberti C. Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology. G Chir 2015;36:187-91. [PMID: 26712075 DOI: 10.11138/gchir/2015.36.4.187] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Vaglio A, Maritati F. Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol 2016;27:1880-9. [PMID: 26860343 DOI: 10.1681/ASN.2015101110] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 9.8] [Reference Citation Analysis]
20 Yachoui R, Sehgal R, Carmichael B. Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol 2016;35:401-7. [PMID: 26208444 DOI: 10.1007/s10067-015-3022-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
21 Girardi M, Martin N. Obstructive Uropathy. Hospital Medicine Clinics 2015;4:328-41. [DOI: 10.1016/j.ehmc.2015.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Moura C, Aquino MA, Rocha Filho J, Santiago M. Takayasu's or tuberculous arteritis? BMJ Case Rep 2015;2015:bcr2014208717. [PMID: 26106169 DOI: 10.1136/bcr-2014-208717] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Swartz RD. Retroperitoneal Fibrosis and Asbestosis—A Plausible Association? American Journal of Kidney Diseases 2015;65:378-80. [DOI: 10.1053/j.ajkd.2014.09.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Alvarez Argote J, Bauer FA, Posteraro AF 3rd, Dasanu CA. Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab! J Oncol Pharm Pract 2016;22:179-85. [PMID: 25013186 DOI: 10.1177/1078155214543279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
25 Laco J, Podhola M, Kamarádová K, Novák I, Dobeš D, Broďák M, Hácová M, Ryška A. Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease. Virchows Arch 2013;463:721-30. [DOI: 10.1007/s00428-013-1480-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
26 Shirani M, Davoudian A, Sharifi A. Retroperitoneal fibrosis associated with propranolol: a case report; is corticosteroid administration necessary after ureterolysis? J Renal Inj Prev 2013;2:67-9. [PMID: 25340131 DOI: 10.12861/jrip.2013.22] [Reference Citation Analysis]